SNGX CIK: 812796

Soligenix Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.7
FY22:
−12.6
FY23:
−8.60
FY24:
−8.40
FY25:
−10.3
Change from FY21 to FY25
millions USD
FY21:
−0.01
FY22:
−0.01
FY23:
–
FY24:
–
FY25:
−0.01
Change from FY21 to FY25
millions USD
FY21:
19.1
FY22:
0.08
FY23:
3.66
FY24:
7.76
FY25:
10.4
millions USD
FY21:
7.37
FY22:
−12.7
FY23:
−4.91
FY24:
−0.63
FY25:
0.12
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.8
FY22:
−12.7
FY23:
–
FY24:
–
FY25:
−10.3

All amounts in millions USD Data source:SEC EDGAR